Clinical Trials Directory

Trials / Completed

CompletedNCT03024112

Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.

Detailed description

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce ICU and hospital length of stay.

Conditions

Interventions

TypeNameDescription
DEVICEHeated humified high-flow nasal cannula Oxygen
OTHERStandard oxygen therapy

Timeline

Start date
2013-08-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2017-01-18
Last updated
2017-12-05
Results posted
2017-12-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03024112. Inclusion in this directory is not an endorsement.